Skip to main content
. 2022 Aug 18;55(1):72–80. doi: 10.3724/abbs.2022114

Figure 6 .


Figure 6

Impact of PI3K/AKT pathway agonist on EMT and proliferation in MOR-silenced CRC cells

(A) Representative western blots showing the expressions of MOR and p-AKT after transfection with sh-MOR or/and treatment with SC79PI3K/AKT pathways agonist in CRC cells. (B) Representative western blots showing the expressions of EMT-markers. (C) Cell proliferation assay and the statistical results. (D,E) Migration and invasion assay and statistical results. * P<0.05 and ** P<0.01.